Browsing by Autor "Mario Villabon"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Thumbnail Image
    Item type: Item ,
    Impact of High-Flow Nasal Cannula Use in Subjects With COVID-19 ARDS at High Altitudes: Clinical Presentation and Prognostic Factors
    (American Association for Respiratory Care, 2023) Daniel Molano-Franco; Antonio Viruez‐Soto; Mario Gómez; Edgar Beltrán; Mario Villabon; Ángela Sosa; Leidy Ortiz; Estefania Orozco; Alejandra Hurtado; Lida Sanchez
    High-altitude subjects treated with HFNC for COVID-19 showed a high risk of respiratory failure and progressive hypoxemia when F<sub>IO<sub>2</sub></sub> requirements were > 0.8 after 24 h of treatment. In these subjects, personalized management should include continuous monitoring of individual clinical conditions (such as oxygenation indices, with cutoffs adapted to those corresponding to high-altitude cities).